IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
IMMUNIC, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.99+0.02 (+0.29%)
Close on Oct 19, 2026
- Market cap
- $297.17M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 13, 2026(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 27, 2026 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 8, 2019(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Apr 15, 2019 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |